my 1250 has been researched along with carbostyril in 13 studies
| Studies (my 1250) | Trials (my 1250) | Recent Studies (post-2010) (my 1250) | Studies (carbostyril) | Trials (carbostyril) | Recent Studies (post-2010) (carbostyril) |
|---|---|---|---|---|---|
| 13 | 1 | 0 | 12,855 | 1,323 | 5,611 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beermann, D; Heibel, B; Kuhlmann, J; Schaefer, HG; Sturm, Y; Wargenau, M | 1 |
| Kadowaki, S; Takahashi, K; Umezu, K; Yamada, N | 1 |
| Endo, K; Takahashi, K; Takei, M | 2 |
| Fujisawa, K; Izushi, K; Kamei, C; Mio, M; Tasaka, K; Yoshii, N | 1 |
| Arai, Y; Endoh, K; Takahashi, K; Yamada, N | 1 |
| Shono, T; Takahashi, K | 1 |
| Endoh, K; Takahashi, K; Yamada, N; Yasumura, K | 1 |
| Arai, Y; Shono, T; Takahashi, K | 1 |
| Kohno, SW; Ohata, K | 1 |
| Hanazuka, M; Hara, Y; Horii, D; Nishi, H | 1 |
| Arai, Y; Funayama, K; Kadowaki, S; Takahashi, K; Umezu, K; Yamada, N | 1 |
| Kovanen, PT; Ma, H | 1 |
1 trial(s) available for my 1250 and carbostyril
| Article | Year |
|---|---|
Pharmacokinetics of the active metabolite of the prodrug repirinast in healthy Caucasian volunteers after a single oral dose.
Topics: Administration, Oral; Analysis of Variance; Chromatography, High Pressure Liquid; Double-Blind Method; Humans; Male; Prodrugs; Quinolones; Reference Values; Reproducibility of Results; White People | 1992 |
12 other study(ies) available for my 1250 and carbostyril
| Article | Year |
|---|---|
MY-1250, a major metabolite of the anti-allergic drug repirinast, induces phosphorylation of a 78-kDa protein in rat mast cells.
Topics: Animals; Calcimycin; Drug Interactions; Histamine Antagonists; Histamine H1 Antagonists; Male; Mast Cells; Phosphorylation; Proteins; Quinolones; Rats; Rats, Wistar | 1992 |
Mechanism of action of MY-1250, an active metabolite of Repirinast, in inhibiting histamine release from rat mast cells.
Topics: Adenosine Triphosphate; Animals; Ascaris; Calcium; Cyclic AMP; Histamine Antagonists; Histamine H1 Antagonists; Histamine Release; In Vitro Techniques; Male; Mast Cells; Passive Cutaneous Anaphylaxis; Peritoneal Cavity; Quinolones; Rats; Rats, Inbred Strains | 1992 |
Inhibition of histamine release from rat peritoneal mast cells by MY-1250, an active metabolite of Repirinast (MY-5116).
Topics: Animals; Calcium; Cromolyn Sodium; Histamine H1 Antagonists; Histamine Release; Male; Mast Cells; Quinolones; Rats; Rats, Inbred Strains | 1990 |
Inhibitory effect of MY-1250 on histamine release from rat peritoneal mast cells and guinea pig lung fragments: the elucidation of the mechanism.
Topics: Animals; Calcium; Cells, Cultured; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; Histamine Release; Inositol 1,4,5-Trisphosphate; Lung; Male; Mast Cells; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Quinolones; Rats; Rats, Inbred Strains | 1991 |
[Inhibitory effect on the release of mediators from rat peritoneal exudate cells and the antagonistic effect against mediators of MY-5116 and other anti-allergic agents].
Topics: Animals; Bradykinin; Chromones; Cromolyn Sodium; Female; Guinea Pigs; Histamine H1 Antagonists; Hypersensitivity; Ketotifen; Male; Muscle, Smooth; ortho-Aminobenzoates; Passive Cutaneous Anaphylaxis; Peritoneal Cavity; Quinolines; Quinolones; Rats; Serotonin Antagonists; SRS-A | 1986 |
[Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic drug, on histamine release from monkey lung fragments].
Topics: Animals; Female; Guinea Pigs; Histamine H1 Antagonists; Histamine Release; Immunoglobulin E; In Vitro Techniques; Lung; Macaca fascicularis; Male; Quinolines; Quinolones | 1986 |
Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic agent, on the release of mediators from guinea pig lung fragments.
Topics: Animals; Female; Guinea Pigs; Histamine H1 Antagonists; Histamine Release; In Vitro Techniques; Lung; Quinolines; Quinolones; SRS-A | 1986 |
[Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic drug, on histamine release from rat peritoneal exudate cells and the degranulation of mesenteric mast cells].
Topics: Animals; Histamine Release; In Vitro Techniques; Male; Mast Cells; Peritoneal Cavity; Quinolines; Quinolones; Rats; Rats, Inbred Strains | 1986 |
[Antiallergic effect of MY-5116 and its major metabolite, MY-1250].
Topics: Animals; Female; Guinea Pigs; Histamine Antagonists; Histamine H1 Antagonists; Histamine Release; Humans; In Vitro Techniques; Lung; Quinolines; Quinolones; Rats; SRS-A | 1986 |
[Cardiovascular effects of MY-5116 and MY-1250].
Topics: Animals; Arteries; Blood Pressure; Cardiovascular System; Cromolyn Sodium; Dogs; Electrocardiography; Female; Ganglia, Sympathetic; Guinea Pigs; Heart Rate; Immunosuppressive Agents; Male; Nictitating Membrane; Quinolines; Quinolones; Rats; Rats, Inbred Strains; Respiration | 1986 |
Effect of a major metabolite of the antiallergic drug repirinast on phosphodiesterase and adenylate cyclase activities.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclase Inhibitors; Animals; Colforsin; Cromolyn Sodium; Exudates and Transudates; Histamine H1 Antagonists; Histamine Release; In Vitro Techniques; Lung; Male; Peritoneal Cavity; Phosphodiesterase Inhibitors; Quinolones; Rats; Rats, Wistar; Theophylline | 1995 |
Inhibition of mast cell-dependent conversion of cultured macrophages into foam cells with antiallergic drugs.
Topics: Animals; Anti-Allergic Agents; Cell Degranulation; Cholesterol Esters; Cholesterol, LDL; Coculture Techniques; Cromolyn Sodium; Foam Cells; Gold; Heparin; Histamine; Immune Sera; Immunoglobulin E; Lipoproteins, LDL; Macrophages, Peritoneal; Male; Mast Cells; Microscopy, Electron; Ovalbumin; Proteoglycans; Quinolones; Rats; Rats, Wistar | 2000 |